Latest updated & new medicines
New medicines
| Product Name | Date Updated | |
|---|---|---|
| pl |
Panadol Children 5-12 Years Reformulated eleaflet
26 May 2025 |
|
| pl |
Panadol Children 1-5 Years Reformulated eleaflet
26 May 2025 |
|
| PI |
Kisunla
22 May 2025 |
|
| cmi |
Kisunla
22 May 2025 |
|
| cmi |
Fluzone
19 May 2025 |
|
What is Medsinfo.com.au?
Our aim
is to support the National Strategy for the Quality Use of Medicines.
What is the goal of the strategy?
The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians.
How do we support this goal?
We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.
The most up-to-date medicine information at your fingertips
Pharmaceutical companies are required by government to keep their medicines information up to date as new information about these medicines becomes available.
This website contains the most up to date version of many Consumer Medicine Information (CMI) and Product Information (PI) that are available in Australia, as the website is updated within hours of the release of the updated CMI and PI by the pharmaceutical company.
Our aim
Is to support the National Strategy for the Quality Use of Medicines.
What is the goal of the strategy?
The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians.
How do we support this goal?
We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.
The most up-to-date medicine information at your fingertips
Pharmaceutical companies are required by government to keep their medicines information up to date as new information about these medicines becomes available.
This website contains the most up to date version of many Consumer Medicine Information (CMI) and Product Information (PI) that are available in Australia, as the website is updated within hours of the release of the updated CMI and PI by the pharmaceutical company.
